Target intelligence / Profile preview

Gastrointestinal secretory processes

Molecular classification
Ion channel (e.g., CFTR, KCNQ1, KCNN4), Transporter (e.g., NKCC1, Na⁺-K⁺-ATPase), G protein-coupled receptor (e.g., GqPCR, GsPCR, M3 receptors), Enzyme (e.g., H⁺/K⁺-ATPase)
01

Overview

Gastrointestinal secretory processes encompass the coordinated release of enzymes, acids, bicarbonate, and fluids across the stomach, small intestine, and colon to facilitate digestion, absorption, and protection of the mucosal lining. These processes are primarily driven by enteroendocrine cells, parietal cells, and epithelial ion transporters, involving key mechanisms like CFTR-mediated Cl⁻ secretion in the intestine, H⁺/K⁺-ATPase-driven acid production in the stomach, and NKCC1-coupled ion uptake. Neural (e.g., acetylcholine via M3 receptors) and hormonal (e.g., VIP, gastrin) signals regulate secretion through cAMP, Ca²⁺, and second messengers, enabling rapid adaptation to nutrient intake. Dysregulation contributes to disorders like secretory diarrhea from toxin-activated CFTR or gastric ulcers from excess acid, and in gastrointestinal cancers, altered secretion ties to cancer stem cell pathways influencing tumor progression. Therapeutically, targets within these processes include proton pump inhibitors for acid suppression and CFTR modulators for diarrhea, though challenges include balancing secretion without disrupting motility or microbiome.

Other names
gastric secretionintestinal secretionGI secretionCl⁻ secretiongastric acid secretion
02

Mechanism of action

cAMP elevation via GsPCRs activating CFTR Cl⁻ channels; Ca²⁺ increase via GqPCRs activating KCNN4 K⁺ channels and Cl⁻ efflux; H⁺ secretion inhibition via H⁺/K⁺-ATPase blockade; NKCC1-mediated ion uptake for Cl⁻ secretion

03

Biological functions

DigestionNutrient absorptionFluid secretionAcid productionHormone release (e.g., GLP-1, gastrin)Motility regulation
04

Disease associations

DiarrheaGastric ulcersInflammatory bowel diseaseGastrointestinal cancers (via CSC-related secretion dysregulation)Infection (e.g., toxin-induced secretion)
05

Safety considerations

Excessive inhibition risks hypochlorhydria and bacterial overgrowthHypersecretion induction causes diarrheaOff-target effects on motility and hormone release (e.g., GLP-1 dysregulation leading to metabolic issues)
06

Interacting drugs

VIP receptor agonists

6 more in the full profile.

07

Biomarkers

CFTR expression levelsNKCC1 activityCSC markers (e.g., CD44, CD133 in GI cancers affecting secretion)pH levels in gastric mucosa

Beyond the preview

Go deeper on Gastrointestinal secretory processes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal secretory processes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call